Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Agrawal

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Stem Cells and Development|July 28, 2012
The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac diseaseAbdul M Mozid, Dan Jones, Samer Arnous, et al.
British Journal of Haematology|May 31, 2013
Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletionJeff K Davies, David Taussig, Heather Oakervee, et al.
Regenerative Medicine|September 19, 2009
Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparationsChia Yeo, Natalie Saunders, Didier Locca, et al.
Blood|December 19, 2012
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine productionJohn C Riches, Jeffrey K Davies, Fabienne McClanahan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 2, 2013
Clinical experience with Zarzio® in Europe: what have we learned?Pere Gascón, Hans Tesch, Karl Verpoort, et al.
Haematologica|December 25, 2016
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsFrederic Tissot, Samir Agrawal, Livio Pagano, et al.
BMJ Open|February 20, 2014
A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI)Stephen Hamshere, Tawfiq Choudhury, Daniel A Jones, et al.
Jac-Antimicrobial Resistance|January 1, 2025
Antifungal stewardship in the UK: where are we now?Silke Schelenz, Samir Agrawal, Aaron Brady, et al.
Critical Reviews in Microbiology|February 14, 2012
A practical critique of antifungal treatment guidelines for haemato-oncologistsSamir Agrawal, Brian Jones, Rosemary Barnes, et al.
British Journal of Haematology|June 15, 2005
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myelomaHeather E Oakervee, Rakesh Popat, Nicola Curry, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Stem Cells and Development|July 28, 2012
The effects of age, disease state, and granulocyte colony-stimulating factor on progenitor cell count and function in patients undergoing cell therapy for cardiac diseaseAbdul M Mozid, Dan Jones, Samer Arnous, et al.
British Journal of Haematology|May 31, 2013
Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletionJeff K Davies, David Taussig, Heather Oakervee, et al.
Regenerative Medicine|September 19, 2009
Ficoll-Paque versus Lymphoprep: a comparative study of two density gradient media for therapeutic bone marrow mononuclear cell preparationsChia Yeo, Natalie Saunders, Didier Locca, et al.
Blood|December 19, 2012
T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine productionJohn C Riches, Jeffrey K Davies, Fabienne McClanahan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 2, 2013
Clinical experience with Zarzio® in Europe: what have we learned?Pere Gascón, Hans Tesch, Karl Verpoort, et al.
Haematologica|December 25, 2016
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patientsFrederic Tissot, Samir Agrawal, Livio Pagano, et al.
BMJ Open|February 20, 2014
A randomised double-blind control study of early intracoronary autologous bone marrow cell infusion in acute myocardial infarction (REGENERATE-AMI)Stephen Hamshere, Tawfiq Choudhury, Daniel A Jones, et al.
Jac-Antimicrobial Resistance|January 1, 2025
Antifungal stewardship in the UK: where are we now?Silke Schelenz, Samir Agrawal, Aaron Brady, et al.
Critical Reviews in Microbiology|February 14, 2012
A practical critique of antifungal treatment guidelines for haemato-oncologistsSamir Agrawal, Brian Jones, Rosemary Barnes, et al.
British Journal of Haematology|June 15, 2005
PAD combination therapy (PS-341/bortezomib, doxorubicin and dexamethasone) for previously untreated patients with multiple myelomaHeather E Oakervee, Rakesh Popat, Nicola Curry, et al.
Pageof 4